Skip to content
Disclosery

EXANE DERIVATIVES: A position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on A, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 32 A shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 32 shares
    Change vs previous 13F -879 shares

    <0.01% of the 13F portfolio, value $3,800.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 911 shares
    Change vs previous 13F -1,228 shares

    0.03% of the 13F portfolio, value $120,545.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,139 shares
    Change vs previous 13F +664 shares

    0.08% of the 13F portfolio, value $341,479.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,475 shares
    Change vs previous 13F -2,571 shares

    0.06% of the 13F portfolio, value $232,348.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,046 shares
    Change vs previous 13F +1,795 shares

    0.14% of the 13F portfolio, value $603,933.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,251 shares
    Change vs previous 13F -942 shares

    0.09% of the 13F portfolio, value $286,179.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 3,193 shares
    Change vs previous 13F not available

    0.11% of the 13F portfolio, value $378,321.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).